Tag Archives: medications

A New Paradigm for Dosing Diabetes Drugs in Type 2 Diabetes?

Which is better, adding medications one at a time or all at once? It’s a question physicians will be pondering as they discuss the results of an ongoing study into how to dose oral medications for people with type 2 … Continue reading

Posted in Research | Tagged , | 2 Comments

New Cholesterol Guidelines Expand Pool of Who Needs Drug Treatment

They are out; they were years in the making and now they are here- the new cholesterol  guidelines- a joint effort by the American College of Cardiology (ACC) and the American Heart Association (AHA). The report is dense, running to … Continue reading

Posted in Diabetes Day2Day | Tagged , , | 2 Comments

Type 1 Diabetes Research Round-up: What’s Happening at Joslin

  Type 1 diabetes is a complicated, complex disease. Conquering this multi-faceted condition requires people working from all angles. At Joslin Diabetes Center, researchers are up to the task. AUTOIMMUNITY In type 1 diabetes, the immune system mistakenly attacks the … Continue reading

Posted in Inside Joslin | Tagged , , , , | 1 Comment

Diabetes Medications and Weight Gain

Both people with type 1 and type 2 diabetes usually gain weight when they begin therapy, either insulin or some type 2 diabetes medications. For many people with type 1, weight gain is advisable due to the loss of lean … Continue reading

Posted in Diabetes Day2Day | Tagged , | 3 Comments

Survey About Medications for People with Type 2 Diabetes

Many new medications for type 2 diabetes have become available in the past several years, but it’s not always clear which medicine is best for which person. Dr. Ruth Hertzman-Miller, part of the Professional Education team at Joslin, is doing a … Continue reading

Posted in Diabetes Day2Day | Tagged , | Leave a comment

Could an Insulin Pill Be in Your Future?

Currently the only way insulin can be delivered is by injection.  Inhaled insulin was available a few years ago, but was withdrawn from the market because of concerns of respiratory illness, and possible lung cancer due to the necessity of … Continue reading

Posted in Diabetes Day2Day | Tagged , , | 6 Comments

Avandia Gets A Mini Reprieve

The FDA advisory panel recently voted to relax restrictions on the thioglitazones drug Avandia®.  Avandia®, previously a big money maker for the pharmaceutical company, Glaxo-Smith Klein, has declined precipitously in usage to just a small percentage of people in recent … Continue reading

Posted in Diabetes Day2Day | Tagged , | Leave a comment

New Drug for Type 2 Diabetes Approved by the FDA

The U.S. Food and Drug Administration recently approved Johnson & Johnson’s first of a new class of anti-diabetes drugs, called Invokana, to treat type 2 diabetes. Type 2 diabetes affects about 24 million people and accounts for more than 90 … Continue reading

Posted in Diabetes Day2Day | Tagged , , | 4 Comments

More Than Pill Dispensers: How Your Pharmacist Can Help Your Diabetes

Despite what those pharmacy commercials exemplifying the close patient pharmacist team tell us, most of us have limited interaction with our druggist. We drop off our prescriptions at one window and pay for them at another. If we have a … Continue reading

Posted in Diabetes Day2Day | Tagged , , | Leave a comment